Skip to content
Home/Companies/MedTech/Route92

Route92

MedTech·United States·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Route92?

Route92 is an American MedTech company, currently owned by Novo Holdings since 2024.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Growth Investments · 1999 · Growth

Key facts

HQUnited States
SectorMedTech
StatusActive

More from Novo Holdings Growth Investments

Other portfolio companies in the same fund.

Surya Hospitals
Active
HealthcareIndia· 2026
Phasecraft
Phasecraft
Active
Deep TechUK· 2025
AvenCell
Active
BiotechUS· 2024
Cleveland Diagnostics
Active
MedTechUS· 2024
Convergent
Active
BiotechUS· 2024
Medi Assist
Active
HealthTechIndia· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Route92?

Route92 is currently owned by Novo Holdings, through Novo Holdings Growth Investments, since 2024.

When did Novo Holdings acquire Route92?

Novo Holdings acquired Route92 in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue